Michael E. Phelps
#66,320
Most Influential Person Now
Michael E. Phelps's AcademicInfluence.com Rankings
Download Badge
Chemistry Physics
Why Is Michael E. Phelps Influential?
(Suggest an Edit or Addition)Michael E. Phelps's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. (1986) (1343)
- Reduction of prefrontal cortex glucose metabolism common to three types of depression. (1989) (1307)
- Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size (1979) (1241)
- Physics in Nuclear Medicine (2004) (1210)
- TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD (1980) (1197)
- Positron emission tomography provides molecular imaging of biological processes. (2000) (1085)
- Systems Biology and New Technologies Enable Predictive and Preventative Medicine (2004) (1060)
- Noninvasive determination of local cerebral metabolic rate of glucose in man. (1980) (1034)
- Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (2001) (863)
- Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. (1987) (817)
- Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. (2000) (734)
- Application of annihilation coincidence detection to transaxial reconstruction tomography. (1975) (685)
- PET of brain amyloid and tau in mild cognitive impairment. (2006) (671)
- Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. (1996) (652)
- Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. (1986) (652)
- A positron-emission transaxial tomograph for nuclear imaging (PETT). (1975) (643)
- Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study. (1997) (614)
- Functional anatomy of human procedural learning determined with regional cerebral blood flow and PET (1992) (612)
- Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. (1995) (608)
- A tabulated summary of the FDG PET literature. (2001) (597)
- Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. (1985) (575)
- Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. (2001) (562)
- PET: the merging of biology and imaging into molecular imaging. (2000) (525)
- Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. (1988) (518)
- Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. (1982) (494)
- Influence of Age and Hemodynamics on Myocardial Blood Flow and Flow Reserve (1993) (486)
- Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. (1995) (478)
- Multistep Synthesis of a Radiolabeled Imaging Probe Using Integrated Microfluidics (2005) (458)
- Impact of animal handling on the results of 18F-FDG PET studies in mice. (2006) (453)
- A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. (2000) (450)
- Positron emission tomography: human brain function and biochemistry. (1985) (450)
- Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia (1983) (447)
- Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. (2005) (441)
- N‐13 Ammonia as an Indicator of Myocardial Blood Flow (1981) (434)
- Quantitation in Positron Emission Computed Tomography (1980) (425)
- Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. (2007) (401)
- Positron emission tomography and autoradiography: Principles and applications for the brain and heart (1985) (387)
- The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. (1983) (379)
- Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy (2007) (379)
- Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. (1992) (377)
- Study of Cerebral Function with Positron Computed Tomography (1982) (376)
- Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. (1999) (363)
- Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. (1995) (359)
- Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder (1999) (358)
- Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects (1981) (356)
- Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method (1982) (349)
- Ex vivo cell labeling with 64Cu–pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography (2002) (337)
- Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. (1987) (334)
- Human functional anatomy of visually guided finger movements. (1992) (326)
- Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. (1986) (325)
- Positron emission tomography scanning: current and future applications. (2002) (319)
- Noninvasive assessment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. V. Detection of 47 percent diameter coronary stenosis with intravenous nitrogen-13 ammonia and emission-computed tomography in intact dogs. (1978) (311)
- Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. (1989) (296)
- Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. (1987) (294)
- Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. (1985) (294)
- ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. (1978) (291)
- FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder (1998) (279)
- Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine (1999) (275)
- 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. (1989) (275)
- Presurgical evaluation for partial epilepsy (1990) (275)
- Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. (1979) (274)
- Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. (1979) (274)
- Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. (1982) (274)
- METABOLIC MAPPING OF THE BRAIN'S RESPONSE TO VISUAL STIMULATION: STUDIES IN HUMANS (1981) (272)
- Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury. (2000) (269)
- Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. (1997) (265)
- Patterns of human local cerebral glucose metabolism during epileptic seizures. (1982) (262)
- Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. (1998) (262)
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. (1982) (258)
- Cancer Detection with Whole‐Body PET Using 2‐[18F]Fluoro‐2-Deoxy‐D-Glucose (1993) (254)
- Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. (1978) (246)
- Somatotopic mapping of the primary motor cortex in humans: activation studies with cerebral blood flow and positron emission tomography. (1991) (242)
- Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. (1979) (239)
- Infantile spasms: II. Lenticular nuceli and brain stem activation on positron emission tomography (1992) (239)
- Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. (1996) (235)
- Quantitation in Positron Emission Computed Tomography: 4. Effect of Accidental Coincidences (1981) (231)
- Quantification of target gene expression by imaging reporter gene expression in living animals (2000) (229)
- Serotonin 1A receptors in the living brain of Alzheimer's disease patients. (2006) (227)
- Tomographic mapping of human cerebral metabolism (1981) (223)
- Effects of Temporal Sampling, Glucose Metabolic Rates, and Disruptions of the Blood—Brain Barrier on the FDG Model with and without a Vascular Compartment: Studies in Human Brain Tumors with PET (1986) (221)
- Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy (2005) (219)
- Tomographic mapping of human cerebral metabolism (1981) (218)
- The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis (2009) (216)
- High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. (2000) (214)
- PET in oncology: will it replace the other modalities? (1997) (211)
- Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. (2005) (211)
- PET: Molecular Imaging and Its Biological Applications (2004) (206)
- Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors (2006) (205)
- Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. (1986) (205)
- Whole-body positron emission tomography: Part I. Methods and performance characteristics. (1992) (204)
- The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. (1992) (201)
- Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. (1999) (200)
- Semiconductor detector systems. (1973) (198)
- C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium. (1982) (198)
- Quantitative Measurement of Local Cerebral Blood Flow in Humans by Positron Computed Tomography and 15O-Water (1983) (197)
- Metabolic Recovery Following Human Traumatic Brain Injury Based on FDG‐PET: Time Course and Relationship to Neurological Disability (2001) (193)
- An extravascular component of contrast enhancement in cranial computed tomography. Part II. Contrast enhancement and the blood-tissue barrier. (1975) (189)
- Molecular imaging of lymphoid organs and immune activation using positron emission tomography with a new 18F-labeled 2′-deoxycytidine analog (2008) (184)
- External Detection and Visualization of Myocardial Ischemia with 11C‐Substrates in Vitro and in Vivo (1976) (182)
- C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II. Kinetics of C- 11 palmitic acid in acutely ischemic myocardium. (1982) (180)
- Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers (1994) (179)
- In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET) (2000) (179)
- Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies (1991) (177)
- Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography. (2006) (177)
- Regional myocardial oxygen consumption determined noninvasively in humans with [1-11C]acetate and dynamic positron tomography. (1989) (176)
- Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas (2008) (176)
- Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign (2010) (176)
- Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. (1998) (175)
- Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. (1993) (175)
- Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease. (1992) (175)
- Cerebral correlates of depressed behavior in rats, visualized using 14C- 2-deoxyglucose autoradiography (1988) (173)
- A Noninvasive Positron Computed Tomography Technique Using Oxygen-15-Labeled Water for the Evaluation of Neurobehavioral Task Batteries (1985) (172)
- Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. (1991) (169)
- An extravascular component of contrast enhancement in cranial computed tomography. Part I. The tissue-blood ratio of contrast enhancement. (1975) (169)
- Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. (1992) (166)
- Effects of a 14-day healthy longevity lifestyle program on cognition and brain function. (2006) (165)
- Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. (1995) (165)
- Effects of increased intracranial pressure on cerebral blood volume, blood flow, and oxygen utilization in monkeys. (1975) (164)
- FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas (2009) (163)
- Correlation of 6-18F-Fluoro-l-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas (2010) (156)
- Design and performance characteristics of a whole-body positron transaxial tomograph. (1976) (154)
- Cerebral glucose metabolic rates in normal human females versus normal males (1987) (153)
- Emission computed tomography. (1977) (152)
- Micro-chemical synthesis of molecular probes on an electronic microfluidic device (2011) (150)
- Integrated microfluidics for parallel screening of an in situ click chemistry library. (2006) (150)
- Noninvasive quantitative imaging of protein–protein interactions in living subjects (2002) (149)
- Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. (1996) (149)
- Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography. (1989) (149)
- Effect of positron range on spatial resolution. (1975) (147)
- Measurements of regional tissue and blood-pool radiotracer concentrations from serial tomographic images of the heart. (1983) (145)
- Positron emission tomography in urological oncology. (1998) (145)
- Attenuation coefficients of various body tissues, fluids, and lesions at photon energies of 18 to 136 keV. (1975) (144)
- Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. (2005) (140)
- Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. (2002) (140)
- PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT. (1989) (137)
- Effect of acute and long-term smoking on myocardial blood flow and flow reserve. (1995) (136)
- Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. (1989) (136)
- Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. (1995) (134)
- Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. (1982) (134)
- 3′-Deoxy-3′-18F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab (2012) (132)
- Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. (1991) (131)
- C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. (1983) (130)
- Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant Lymphoma (2001) (130)
- Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. (1996) (129)
- Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey (1997) (127)
- Intraoperative beta probe: a device for detecting tissue labeled with positron or electron emitting isotopes during surgery. (1994) (127)
- Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. (1998) (124)
- Tomographic images of blood pool and perfusion in brain and heart. (1976) (124)
- Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. (2001) (123)
- Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. (2005) (122)
- Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. (2009) (122)
- A BOUNDARY METHOD FOR ATTENUATION CORRECTION IN POSITRON COMPUTED TOMOGRAPHY (1981) (121)
- 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. (2011) (120)
- Cerebral hemodynamics and metabolism in pseudotumor cerebri (1978) (119)
- 18F-FDOPA PET for Differentiating Recurrent or Progressive Brain Metastatic Tumors from Late or Delayed Radiation Injury After Radiation Treatment (2014) (117)
- Cerebral glucose metabolism in Wernicke's, Broca's, and conduction aphasia. (1989) (117)
- Quantitation in Positron Emission Computed Tomography: 6. Effect of Nonuniform Resolution (1982) (117)
- Design features and performance of a PET system for animal research. (1992) (116)
- Metabolic Maturation of the Brain: A Study of Local Cerebral Glucose Utilization in the Developing Cat (1991) (116)
- Interictal cerebral metabolism in partial epilepsies of neocortical origin (1991) (116)
- A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease (1990) (115)
- FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? (2002) (115)
- Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET. (1990) (115)
- Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective. (2001) (113)
- Cerebellar glucose metabolism in chronic aphasia (1987) (113)
- Imaging of pulmonary mass lesions with whole‐body positron emission tomography and fluorodeoxyglucose (1993) (113)
- A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. (1993) (113)
- In vivo measurement of brain glucose transport and metabolism employing glucose- -11C. (1975) (112)
- Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. (2004) (111)
- Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium. (1985) (111)
- Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy (2014) (111)
- Whole-Body 18F-FDG PET and Conventional Imaging for Predicting Outcome in Previously Treated Breast Cancer Patients (2002) (111)
- Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET. (2005) (110)
- Correlation of regional metabolic rates of glucose with glasgow coma scale after traumatic brain injury. (2003) (110)
- 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab. (2012) (110)
- Interictal and postictal focal hypermetabolism on positron emission tomography. (1993) (109)
- The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma. (2018) (109)
- Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. (1993) (108)
- Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas (2008) (108)
- Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors (2008) (107)
- Positron Emission Tomography of the Brain (1983) (106)
- Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats. (1990) (106)
- PET imaging of transgene expression (2000) (105)
- Phase I, First-in-Human Study of BMS747158, a Novel 18F-Labeled Tracer for Myocardial Perfusion PET: Dosimetry, Biodistribution, Safety, and Imaging Characteristics After a Single Injection at Rest (2011) (104)
- Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. (1989) (104)
- Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients (2005) (104)
- Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors (2008) (104)
- Selective metabolic reduction in gray matter acutely following human traumatic brain injury. (2004) (104)
- In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography. (1981) (103)
- The use of positron emission tomography in the clinical assessment of dementia. (1992) (102)
- Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. (1993) (101)
- Performance evaluation of a positron tomograph designed for brain imaging. (1983) (100)
- Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. (1992) (100)
- Estrogen use and brain metabolic change in postmenopausal women (2004) (99)
- An integrated microfluidic device for large-scale in situ click chemistry screening. (2009) (99)
- A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. (2010) (99)
- Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. (2003) (99)
- Surgical treatment of intractable neonatal‐onset seizures (1988) (98)
- Hemimegalencephaly: evaluation with positron emission tomography. (1993) (98)
- Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. (1995) (98)
- Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography (2005) (97)
- Automated iterative three-dimensional registration of positron emission tomography images. (1993) (97)
- Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel. (2005) (94)
- In Vivo Quantitation of Glucose Metabolism in Mice Using Small-Animal PET and a Microfluidic Device (2007) (94)
- Design Considerations for a Positron Emission Transaxial Tomograph (PETT III) (1976) (93)
- Radiation dose estimates in humans for (11)C-acetate whole-body PET. (2004) (93)
- Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine. (1981) (93)
- The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. (2002) (92)
- Quantitating tumor glucose metabolism with FDG and PET. (1992) (92)
- C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs. (1983) (92)
- Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. (1987) (91)
- Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. (1991) (91)
- An analysis of signal amplification using small detectors in positron emission tomography. (1982) (91)
- Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. (1997) (90)
- Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. (1999) (90)
- 18F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib (2011) (90)
- Collection of scintillation light from small BGO crystals (1995) (90)
- Clinical Value of Neuroimaging in the Diagnosis of Dementia. Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease. (1999) (88)
- Cerebral Extraction of N‐13 Ammonia: Its Dependence on Cerebral Blood Flow and Capillary Permeability — Surface Area Product (1981) (88)
- Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. (2013) (86)
- Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. (1986) (85)
- Changes in Tumor Metabolism as Readout for Mammalian Target of Rapamycin Kinase Inhibition by Rapamycin in Glioblastoma (2008) (85)
- The differential diagnosis of depression. Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy. (1987) (84)
- Quantitation in Positron Emission Computed Tomography: 3. Effect of Sampling (1980) (84)
- Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. (1999) (84)
- LOCAL CEREBRAL BLOOD VOLUME IN HEAD‐INJURED PATIENTS. DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 99mTc‐LABELED RED CELLS (1980) (84)
- Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-d-glucose uptake in positron emission tomography studies of normal humans (1993) (84)
- Noninvasive, repetitive, quantitative measurement of gene expression from a bicistronic message by positron emission tomography, following gene transfer with adenovirus. (2002) (83)
- Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs (2008) (83)
- The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. (1992) (82)
- Factors Which Affect Cerebral Uptake and Retention of 13NH3 (1977) (81)
- Decision Analysis for the Cost-Effective Management of Recurrent Colorectal Cancer (2001) (80)
- The impact of PET on the management of lung cancer: the referring physician's perspective. (2002) (80)
- Noninvasive Measurement of Myocardial Activity Concentrations and Perfusion Defect Sizes in Rats With a New Small-Animal Positron Emission Tomograph (2002) (80)
- Estimation of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. (1982) (79)
- Assessment of regional myocardial ischemia by positron-emission computed tomography. (1982) (79)
- Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress (2012) (79)
- Positron computed tomography for studies of myocardial and cerebral function. (1983) (78)
- Correlation of effective atomic number and electron density with attenuation coefficients measured with polychromatic x rays. (1975) (78)
- Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. (1995) (78)
- Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis (2007) (78)
- Electrocardiographic gating in positron emission computed tomography. (1979) (77)
- Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion. (1997) (77)
- 18F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy (2012) (75)
- Requirement for deoxycytidine kinase in T and B lymphocyte development (2009) (75)
- Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. (2006) (74)
- Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. (2002) (74)
- Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. (1985) (73)
- Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. (1994) (73)
- Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects. (1992) (73)
- Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury. (2004) (73)
- Synthesis of a new heterobifunctional linker, N-[4-(aminooxy)butyl]maleimide, for facile access to a thiol-reactive 18F-labeling agent. (2003) (73)
- Transaxial tomographic imaging of canine myocardium with 11C-palmitic acid. (1977) (72)
- The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans. (1990) (72)
- A phenotypic small-molecule screen identifies an orphan ligand-receptor pair that regulates neural stem cell differentiation. (2007) (72)
- Developmental changes in brain metabolism in sedated rhesus macaques and vervet monkeys revealed by positron emission tomography. (1995) (72)
- Detection of immune responses after immunotherapy in glioblastoma using PET and MRI (2017) (71)
- Dynamic, Gated and High Resolution Imaging with the ECAT III (1986) (71)
- Imaging human brain development with positron emission tomography. (1991) (70)
- Detection of coronary artery disease with positron emission tomography and rubidium 82. (1992) (69)
- The effect of steroids on the extravascular distribution of radiographic contrast material and technetium pertechnetate in brain tumors as determined by computed tomography. (1976) (69)
- Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. (1980) (68)
- Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. (2003) (67)
- Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. (1997) (67)
- ECAT III -- Basic Design Considerations (1983) (67)
- Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. (2009) (67)
- Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis. (1986) (66)
- L-6-[18F]Fluoro-DOPA Metabolism in Monkeys and Humans: Biochemical Parameters for the Formulation of Tracer Kinetic Models with Positron Emission Tomography (1991) (66)
- Noninvasive imaging of islet grafts using positron-emission tomography. (2006) (66)
- Regional cerebral blood volume in humans. X-ray fluorescence studies. (1973) (66)
- Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective (2015) (65)
- Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. (1992) (65)
- Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. (1991) (64)
- Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells. (2003) (63)
- Temporoparietal cortex in aphasia. Evidence from positron emission tomography. (1990) (63)
- Positron emission computed tomography in the diagnosis of dementia. (1981) (62)
- Criteria for the tracer kinetic measurement of cerebral protein synthesis in humans with positron emission tomography (1984) (62)
- Positron Emission Tomography in Evaluation of Dementia (2001) (62)
- PET in clinical oncology (1988) (62)
- [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity (2016) (62)
- PET: A biological imaging technique (1991) (62)
- A general technique for interstudy registration of multifunction and multimodality images (1994) (61)
- Correlation between PaCO2 and regional cerebral blood volume by x-ray fluorescence. (1973) (61)
- Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies. (2003) (61)
- Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. (1989) (61)
- Positron emission tomography. (1979) (61)
- Correlation Between Glycolytic Phenotype and Tumor Grade in Soft-Tissue Sarcomas by 18F-FDG PET (2010) (61)
- Emission tomography of the heart. (1980) (60)
- Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease. (2001) (60)
- Anatomical localization schemes for use in positron computed tomography using a specially designed headholder. (1982) (60)
- Synthesis of 8-[18F]fluoroguanine derivatives: in vivo probes for imaging gene expression with positron emission tomography ☆ (2000) (60)
- Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structures. (1995) (60)
- Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. (2003) (60)
- 4‐[18F]Fluoro‐L‐m‐Tyrosine: An L‐3,4‐Dihydroxyphenylalanine Analog for Probing Presynaptic Dopaminergic Function with Positron Emission Tomography (1989) (60)
- Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease. (2000) (59)
- Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. (1985) (59)
- The C15O2 Build-up Technique to Measure Regional Cerebral Blood Flow and Volume of Distribution of Water (1989) (58)
- Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and Neuroimaging a (1996) (58)
- Quantitative Assessment of Prolonged Metabolic Abnormalities in Reperfused Canine Myocardium (1992) (57)
- Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death. (2006) (57)
- Derivation of input function from FDG-PET studies in small hearts. (1996) (57)
- TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE (1981) (57)
- Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. (1999) (56)
- 18 – Imaging Brain Function with Positron Emission Tomography (2002) (56)
- Evaluation of myocardial metabolism, with N-13- and C-11-labeled amino acids and positron computed tomography. (1982) (55)
- Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis. (1993) (55)
- Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography (2009) (54)
- Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. (1994) (53)
- Localization of neurochemical effects of cocaine and other stimulants in the human brain. (1988) (53)
- In vivo regional cerebral blood volume by x-ray fluorescence: validation of method. (1973) (53)
- Integrated microfluidic and imaging platform for a kinase activity radioassay to analyze minute patient cancer samples. (2010) (53)
- Issues in the quantitation of reoriented cardiac PET images. (1992) (53)
- Accuracy of a method using short inhalation of (15)O-O(2) for measuring cerebral oxygen extraction fraction with PET in healthy humans. (2004) (53)
- Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin’s Lymphoma (2009) (53)
- An investigation of a double-tracer technique for positron computerized tomography. (1982) (53)
- Biological imaging and the molecular basis of dopaminergic diseases. (1997) (52)
- Use of positron emission tomography in oncology. (1993) (52)
- Regional cerebral glucose metabolism in clinical subtypes of cerebral palsy. (1991) (52)
- The Changing Design of Positron Imaging Systems. (1998) (52)
- Tomographic mapping of human cerebral metabolism visual stimulation and deprivation. (1981) (51)
- Kinetics of 3′-Deoxy-3′-18F-Fluorothymidine During Treatment Monitoring of Recurrent High-Grade Glioma (2010) (51)
- Dependence of 13NH3 myocardial extraction and clearance on flow and metabolism. (1982) (50)
- Local cerebral metabolic rates of glucose in movement and language disorders from positron tomography. (1984) (50)
- Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective (2012) (49)
- Novel PET Probes Specific for Deoxycytidine Kinase (2010) (49)
- Small Animal Imaging Center Design: The Facility at the UCLA Crump Institute for Molecular Imaging (2005) (49)
- Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. (2001) (48)
- Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. (2002) (47)
- Brain glucose metabolism and memory functions: age decrease in factor scores. (1985) (47)
- Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes (2005) (47)
- Surprisal analysis characterizes the free energy time course of cancer cells undergoing epithelial-to-mesenchymal transition (2014) (47)
- A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. (1991) (46)
- 18F-FLT and 18F-FDOPA PET kinetics in recurrent brain tumors (2014) (46)
- Evaluating tumor biology and oncological disease with positron-emission tomography. (1998) (46)
- Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. (2008) (45)
- 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. (1990) (45)
- BLD: A Software System for Physiological Data Handling and Model Analysis (1981) (45)
- Discriminant Analysis of 18F-Fluorothymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma (2011) (45)
- An Internet-Based “Kinetic Imaging System” (KIS) for MicroPET (2005) (44)
- Microfluidic-Based 18F-Labeling of Biomolecules for Immuno–Positron Emission Tomography (2011) (44)
- A theoretical study of quantitative flow measurements with constant infusion of short-lived isotopes. (1979) (44)
- Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. (2001) (44)
- Quantification of Cerebral Glucose Metabolic Rate in Mice Using 18F-FDG and Small-Animal PET (2009) (44)
- Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen (2008) (44)
- MOLECULAR IMAGING WITH POSITRON EMISSION TOMOGRAPHY (2003) (42)
- Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. (2002) (42)
- Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization. (2005) (42)
- Acid-catalyzed thermal decomposition of 1-aryl-3,3-dialkyltriazenes in the presence of nucleophiles (1990) (41)
- Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies. (1995) (41)
- Engineered Antibody Fragments with Infinite Affinity as Reporter Genes for PET Imaging (2008) (41)
- Quantitation in Positron Emission Tomography: 8. Effects of Nonlinear Parameter Estimation on Functional Images (1987) (41)
- Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway (2010) (41)
- Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. (1987) (41)
- Characterization of a whole body imaging technique for PET (1990) (41)
- Parameter estimation of cardiac geometry by ECG-gated PET imaging: validation using magnetic resonance imaging and echocardiography. (1995) (40)
- Estrogen use and brain metabolic change in older adults. A preliminary report (2001) (40)
- Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia. (1983) (40)
- Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET. (2006) (40)
- Modelling approach for separating blood time-activity curves in positron emission tomographic studies. (1991) (39)
- Glucose Metabolism during Ischemia Due to Excessive Oxygen Demand or Altered Coronary Flow in the Isolated Arterially Perfused Rabbit Septum (1981) (39)
- 6-[18F]Fluoro-l-DOPA metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography (1991) (39)
- Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy. (1989) (39)
- Pitfalls in the measurement of cerebral blood volume with computed tomography. (1976) (39)
- No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography. (1986) (39)
- Cerebral Metabolism following Neonatal or Adult Hemineodecortication in Cats: I. Effects on Glucose Metabolism Using [14C]2-Deoxy-D-Glucose Autoradiography (1996) (39)
- The Peripheral Zone of Increased Density in Cranial Computed Tomography1 (1975) (39)
- Tantalum [18O]water target for the production of [18F]fluoride with high reactivity for the preparation of 2-deoxy-2-[18F]fluoro-D-glucose. (2002) (38)
- A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. (1992) (38)
- A New Tomograph for Quantitative Positron Emission Computed Tomography of the Brain (1981) (38)
- An analysis of some of the physical aspects of positron transaxial tomography. (1976) (38)
- In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography (2008) (38)
- Radiation Dose Estimates for [18F]5-Fluorouracil Derived from PET-Based and Tissue-Based Methods in Rats (2008) (38)
- Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography. (2005) (37)
- Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. (1997) (37)
- Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication (2014) (37)
- Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: A preliminary report (1991) (37)
- Local cerebral glucose metabolic response to audiovisual stimulation and deprivation: studies in human subjects with positron CT. (1983) (36)
- A Double-Injection Technique for in vivo Measurement of Dopamine D2-Receptor Density in Monkeys with 3-(2'-[18F] Fluoroethyl)Spiperone and Dynamic Positron Emission Tomography (1989) (36)
- 18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome. (2005) (35)
- Physics in nuclear medicine. Second edition (1987) (34)
- Multimodal Imaging of Alzheimer Pathophysiology in the Brain's Default Mode Network (2011) (34)
- Synthesis and myocardial kinetics of N-13 and C-11 labeled branched-chain L-amino acids. (1983) (34)
- [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. (1989) (33)
- Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies (1998) (33)
- Radionuclide evaluation of liver transplants. (1988) (33)
- Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. (1995) (33)
- Disconnection and cerebral metabolism. The case of conduction aphasia. (1988) (32)
- A Study of the Single Compartment Tracer Kinetic Model for the Measurement of Local Cerebral Blood Flow Using 15O-Water and Positron Emission Tomography (1987) (32)
- Performance of the rotating slant-hole collimator for the detection of myocardial perfusion abnormalities. (1982) (32)
- Performing radiosynthesis in microvolumes to maximize molar activity of tracers for positron emission tomography (2018) (31)
- Automated image registration for FDOPA PET studies. (1996) (31)
- Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. (1987) (31)
- Regional brain metabolism during seizures in humans. (1983) (31)
- Longitudinal Behavioral and 6-[18F]Fluoro-l-DOPA-PET Assessment in MPTP-Hemiparkinsonian Monkeys (1996) (30)
- Prospects for both precision and accuracy in positron emission tomography (1984) (30)
- Production of diverse PET probes with limited resources: 24 18F-labeled compounds prepared with a single radiosynthesizer (2017) (30)
- Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease. (2006) (29)
- Predicting Seizure-Free Status for Temporal Lobe Epilepsy Patients Undergoing Surgery: Prognostic Value of Quantifying Maximal Metabolic Asymmetry Extending over a Specified Proportion of the Temporal Lobe (2007) (29)
- Regioselective Fluorination of Substituted Guanines with Dilute F(2): A Facile Entry to 8-Fluoroguanine Derivatives. (1996) (29)
- The impact of 2-deoxy-2[18F] fluoro-D-glucose whole body positron emission tomography for managing patients with melanoma: the referring physician's perspective. (2002) (29)
- FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas (2009) (28)
- Regulation of myocardial blood flow response to mental stress in healthy individuals. (2000) (28)
- Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. (1994) (28)
- Studies in persons at risk for Huntington's disease. (1987) (27)
- The Effects of lodinated Contrast Agents on Autoregulation of Cerebral Blood Flow (1974) (27)
- Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them? (1999) (27)
- Investigation of a Technique for Providing a Pseudo-Continuous Detector Ring for Positron Tomography (1982) (27)
- Trazodone treatment response in obsessive-compulsive disorder--correlated with shifts in glucose metabolism in the caudate nuclei. (1987) (26)
- Semiautomatic Software For Quantitative Analysis Of Cardiac Positron Tomography Studies (1988) (25)
- Positron emission tomography scanning in cancer. (1994) (25)
- Design of the Neuro-ECAT®: A High-Resolution, High Efficiency Positron Tomograph for Imaging the Adult Head or Infant Torso (1981) (25)
- Localization of Motor Areas Adjacent to Arteriovenous Malformations: A Positron Emission Tomographic Study (1994) (25)
- Ethological and 6-[18F]fluoro-l-DOPA-PET profiles of long-term vulnerability to chronic amphetamine (1997) (25)
- Responses of blood flow, oxygen consumption, and contractile function to inotropic stimulation in stunned canine myocardium. (1994) (25)
- RESEARCH A RTICLE Usefulness of 3 0 -(F-18)Fluoro-3 0 -deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy (2006) (25)
- Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography. (2013) (25)
- Identification of seizure-mediating brain structures with the deoxyglucose method: studies of human epilepsy with positron emission tomography, and animal seizure models with contact autoradiography. (1986) (25)
- Elemental Fluorine to 8-Fluoropurines in One Step (1996) (24)
- Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy. (1996) (24)
- Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy (2004) (24)
- In vivo assessment of neurotransmitter biochemistry in humans. (1988) (23)
- Appraisal of the angiographic circulation time as an index of cerebral blood flow. (1975) (23)
- Imaging metabolism and biochemistry--a new look at the heart. (1983) (23)
- Metabolic and ultrastructural abnormalities during ischemia in canine myocardium: noninvasive assessment by positron emission tomography. (1987) (22)
- The extraction of the yet unused wealth of information in diagnostic radiology. (1974) (22)
- NanoSystems biology. (2003) (21)
- ELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers (2013) (21)
- INDs for PET Molecular Imaging Probes—Approach by an Academic Institution (2014) (21)
- PET imaging: An overview and instrumentation (1990) (21)
- LOCAL CEREBRAL BLOOD VOLUME IN HEAD-INJURED PATIENTS. DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 99mTc-LABELED RED CELLS (1980) (21)
- Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. (1991) (21)
- N-Fluoro lactams: rapid, mild, and regiospecific fluorinating agents (1990) (20)
- Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies. (1993) (20)
- 13N-labeled L-amino acids for in vivo assessment of local myocardial metabolism. (1981) (20)
- Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging (2018) (20)
- Production of monoenergetic x-rays from 8 to 87 keV. (1974) (20)
- Biodistribution and Predictive Value of 18F-Fluorocyclophosphamide in Mice Bearing Human Breast Cancer Xenografts (2007) (20)
- Evaluating the Performance of Multiplane Positron Tomographs Designed for Brain Imaging (1982) (20)
- EFFECTS OF INCREASED INTRACRANIAL PRESSURE ON CEREBRAL BLOOD VOLUME, BLOOD FLOW, AND OXYGEN UTILIZATION IN MONKEYS (1976) (19)
- Halogen exchange reactions between alkyl halides and aqueous hydrogen halides. A new method for preparation of alkyl halides. (1990) (19)
- Epithelial uptake of [18F]1-(2'-deoxy-2'-arabinofuranosyl) cytosine indicates intestinal inflammation in mice. (2010) (19)
- Surface Feature-Guided Mapping of Cerebral Metabolic Changes in Cognitively Normal and Mildly Impaired Elderly (2009) (19)
- In Vivo Quantitation of Regional Myocardial Blood Flow by Positron‐emission Computed Tomography (1981) (19)
- Positron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver (2014) (19)
- Effects of anoxia on kinetics of [13N] glutamate and 13NH3 metabolism in rabbit myocardium. (1987) (19)
- PET investigation of post-traumatic cerebral blood volume and blood flow. (2003) (19)
- Kinetic characterization of 13NH3 and [13N]glutamine metabolism in rabbit heart. (1984) (18)
- The effects of iodinated contrast agents on autoregulation of cerebral blood flow. (1974) (18)
- A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. (1993) (18)
- Factor analysis in prostate cancer: delineation of organ structures and automatic generation of in- and output functions (2002) (18)
- Positron Emission Reconstruction Tomography For The Assessment Of Regional Myocardial Metabolism By The Administration Of Substrates Labeled With Cyclotron Produced Radionuclides (1976) (18)
- Design and application of the MARK IV scanning system for radionuclide computed tomography of the brain (1976) (18)
- Maximal entropy inference of oncogenicity from phosphorylation signaling (2010) (17)
- Metabolic Imaging Allows Early Prediction of Response to Vandetanib (2011) (17)
- Initial clinical experience with 18F-2-fluoro-2-deoxy-d-glucose for determination of local cerebral glucose utilization by emission computed tomography. (1977) (17)
- Differential FDDNP PET patterns in nondemented middle-aged and older adults. (2009) (17)
- Efficient conversion of 1-aryl-3, 3-dialkyltriazenes to phenols and oxygen-18 labeled phenols (1990) (17)
- Ammonia Myocardial Imaging at Rest and With Exercise in Normal Volunteers Quantification of Absolute Myocardial Perfusion With Dynamic Positron Emission Tomography (2005) (16)
- Quantification of serial tumor glucose metabolism. (1996) (16)
- A modeling-based factor extraction method for determining spatial heterogeneity of Ga-68 EDTA kinetics in brain tumors (1996) (16)
- Epileptic patterns of local cerebral metabolism and perfusion in man: investigation by emission computed tomography of 18F-fluorodeoxyglucose and 13N-ammonia. (1978) (16)
- Factor Analysis for Extraction of Blood (1995) (16)
- Molecular Imaging and Biology (2003) (16)
- REGIONAL CEREBRAL ACTIVITY IN NORMAL AND PATHOLOGIC PERCEPTION OF VISCERAL PAIN: AN O-15-WATER PET STUDY OF HEALTHY SUBJECTS AND IBS PATIENTS (1996) (16)
- A Realistic Computer-Simulated Brain Phantom for Evaluation of PET Charactenstics (1987) (16)
- Nuclear medicine, molecular imaging, and molecular medicine. (2002) (15)
- 18F-FluoroDeoxyGlucose Uptake of Bone and Soft Tissue Sarcomas in Pediatric Patients (2011) (15)
- Positron tomography: "in vivo" autoradiographic approach to measurement of cerebral hemodynamics and metabolism. (1977) (15)
- COINCIDENCE DETECTION TO TRANSAXIAL RECONSTRUCTION TOMOGRAPHY (1974) (15)
- Correlation of brain amyloid with “aerobic glycolysis”: A question of assumptions? (2010) (15)
- Positron-emission tomography in tardive dyskinesia. (1995) (15)
- Small-Animal PET/CT for Monitoring the Development and Response to Chemotherapy of Thymic Lymphoma in Trp53−/− Mice (2010) (15)
- Design Considerations in Positron Computed Tomography (PCT) (1979) (15)
- The use of positron emission tomography imaging in the management of patients with ischemic cardiomyopathy. (1996) (15)
- Measure of regional cerebral blood volume in vivo by means of excited fluorescent x-radiation, and factors affecting this parameter. (1971) (15)
- Specific brain system mediation of obsessive-compulsive disorder responsive to either medication or behavior therapy. (2000) (15)
- Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. (2003) (15)
- A New Technique For Elastic Registration Of Tomographic Images (1988) (14)
- Anomalous 52+ and 72+ states in 99Rh from the decay of 21 min 99Pd (1969) (14)
- Changes in cerebral blood volume and vascular mean transit time during induced cerebral seizures. (1976) (14)
- Development of 2-Deoxy-2-[(18)F]fluororibose for Positron Emission Tomography Imaging Liver Function in Vivo. (2015) (14)
- Helium ion-induced fission of 194Pt, 195Pt and 196Pt at 41 and 34 MeV (1965) (13)
- Discriminant Analysis of 18 F-Fluoro-Thymidine Kinetic Parameters to Predict Survival in Patients with Recurrent High-Grade Glioma (2011) (13)
- Factor analysis for delineation of organ structures, creation of in- and output functions, and standardization of multicenter kinetic modeling (1999) (13)
- What is the purpose of emission computed tomography in nuclear medicine. (1977) (13)
- Positron computed tomography. (1982) (13)
- N-13 Labeled Ammonia and Positron Emission Computerized Axial Tomography (1979) (13)
- Evaluating dementia using PET: how do we put into clinical perspective what we know to date? (2000) (13)
- First human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion imaging (2008) (12)
- Human neuropsychological imaging studies of local brain metabolism: strategies and results. (1985) (12)
- Decay of 39-dayRu103and 17-dayPd103to the levels ofRh103 (1976) (12)
- The Use of Positron Emission Tomography in the Surgical Treatment of Epilepsy (1987) (12)
- Striatal Kinetic Modeling of FDOPA with a Cerebellar-Derived Constraint on the Distribution Volume of 3OMFD: A PET Investigation using Non-Human Primates (2000) (12)
- Synthesis and liposome encapsulation of a novel 18F-conjugate of ω-conotoxin GVIA for the potential imaging of N-type Ca2+ channels in the brain by positron emission tomography (2006) (12)
- Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. (2004) (12)
- Dynamic changes in cerebral glucose metabolism in conscious infant monkeys during the first year of life as measured by positron emission tomography. (2000) (12)
- The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies. (1995) (12)
- Measurement of C-11 palmitate kinetics after metabolic interventions in normals and patients with cardiomyopathy using positron emission computed tomography (1982) (12)
- Electrophilic and nucleophilic approaches to the synthesis of 3-fluorodiazepam (1987) (12)
- Phase 1 rest-stress study of F-18 labeled BMS747158 myocardial perfusion PET tracer: Human safety, dosimetry, biodistribution, and myocardial imaging characteristics (2009) (12)
- National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
- Emission Computed Tomography Simulator (1980) (12)
- Regional abnormality of oxygen consumption in reperfused myocardium assessed with [1-11C] acetate and positron emission tomography (1989) (11)
- Electrophilic azidation for stereoselective synthesis of 2-azido-2-deoxyaldono-1,5-lactones. (2001) (11)
- Quantification of the extent and severity of perfusion defects in canine myocardium by PET polar mapping. (1994) (11)
- chapter 14 – The Gamma Camera: Performance Characteristics (2012) (11)
- LEVEL STRUCTURE OF $sup 101$Rh FROM THE DECAY OF 8.5 h $sup 101$Pd. (1970) (11)
- The peripheral zone of increase density in cranial computed tomography. (1975) (11)
- Fast Metabolic Response to Drug Intervention Through Analysis on a Miniaturized, Highly Integrated Molecular Imaging System (2013) (11)
- Increased false alarms in a subset of persons at-risk for Huntington's disease. (1990) (10)
- Metabolic Assessment of Functional Maturation and Neuronal Plasticity in the Human Brain (1989) (10)
- Dual spillover problem in the myocardial septum with nitrogen-13-ammonia flow quantitation. (1998) (10)
- Performance evaluation of PETbox: A low cost bench top PET scanner dedicated to high throughput preclinical imaging (2009) (10)
- Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle. (1997) (10)
- Positron computed tomography for the in vivo assessment of regional myocardial function. (1984) (10)
- Positron Tomography (1979) (10)
- F-18 fluoride PET : is non-invasive quantitation feasible with factor analysis ? (1997) (10)
- Positron tomography of the heart. (1980) (10)
- Basic principles of positron emission tomography in oncology: quantitation and whole body techniques. (1994) (9)
- chapter 7 – Radiation Detectors (2012) (9)
- Human Sensory Stimulation and Deprivation as Demonstrated by Positron Computed Tomography (1983) (9)
- Positron computed tomography studies of cerebral metabolic responses to complex motor tasks (1984) (9)
- Brain Imaging in Small Animals Using MicroPET (1998) (9)
- Cerebral glucose utilization and blood flow in Huntington's Disease (HD) (1985) (9)
- Cubic Splines for Filter Design in Computed Tomography (1980) (9)
- Microfluidic-Based 18 F-Labeling of Biomolecules for Immuno – Positron Emission Tomography (2011) (9)
- Brain imaging of glucose utilization in convulsive disorders. (1985) (9)
- Neural Mechanisms Supporting Successful Social Decisions in Simians (1996) (9)
- Application of positron emission tomography to determine cerebral glucose utilization in conscious infant monkeys (1999) (8)
- Emission computed tomography in the study of human epilepsy. (1983) (8)
- PET Parametric Response Mapping for Clinical Monitoring and Treatment Response Evaluation in Brain Tumors. (2013) (8)
- Radiation Dose Estimates in Humans for 11 CAcetate CAcetate CAcetate Whole-Body PET (2004) (8)
- An animal model for in vivo evaluation of tumor glycolytic rates with positron emission tomography (1993) (8)
- Comments and Perspectives (2004) (8)
- Applications of Positron Emission Tomography (PET) in Tumor Management (1988) (8)
- Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy (2020) (8)
- Production of short-lived isotopes by charged particle accelerators ((d,n) and (p,n) reactions) (1973) (7)
- Synthesis of an 18F‐fluorobenzoate idarubicin derivative as new potential PET radiotracer to predict chemotherapy resistance (2005) (7)
- P2-206 In vivo brain imaging of tau aggregation in frontal temporal dementia using [F-18]FDDNP positron emission tomography (2004) (7)
- In vivo measurement of cerebral glucose metabolism employing 11C-labeled glucose. (1973) (7)
- Monitoring Gene Therapy by Positron Emission Tomography (2003) (7)
- Development of position sensitive detectors for use in positron emission tomography of small laboratory animals (1994) (7)
- Positron-emitting labeled L-amino acids for measurement of protein synthesis (1982) (7)
- [18F]Fluoro-beta-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys. (1999) (7)
- Plug-and-play modules for flexible radiosynthesis. (2013) (7)
- Deoxyglucose method for the estimation of local myocardial glucose metabolism with positron computed tomography (1981) (6)
- Glucose metabolism of regional myocardial ischemia evaluated by 18fluoro-2-deoxyglucose and positron emission computed tomography (1980) (6)
- Correlation of Regional Cerebral Blood Volume with PaCO 2 and Arterial Blood Pressure (1975) (6)
- An evaluation of Bayesian regression for estimating cerebral oxygen utilization with oxygen-15 and dynamic PET. (1988) (6)
- Nitrogen-13 flux from L-[13N]glutamate in the isolated rabbit heart: effect of substrates and transaminase inhibition. (1986) (6)
- Evaluation of infarcted and ischemic myocardium with 18-fluorodeoxyglucose,13NH3, and positron computed tomography (1981) (6)
- External Detection and Visualization of Myocardial Ischemia with x ̂Substrates x ̂Substrates x ̂Substrates in Vitro and in Vivo (2005) (6)
- chapter 17 – Single Photon Emission Computed Tomography (2012) (6)
- Cost effectiveness of Positron Emission Tomography (PET) in the management of ischemic cardiomyopathy patients who are referred for cardiac transplantation (1996) (6)
- Proceedings: An inherently stable system for measuring tissue iodine using its K-absorption edge. (1974) (6)
- Epileptic patterns of local cerebral metabolism and perfusion in man determined by emission computed tomography of /sup 18/FDG and /sup 13/NH/sub 3/ (1979) (6)
- Preparation of pure carrier-free 123Xe for rare-gas washout studies. (1973) (5)
- Quantitation of regional myocardial blood flow by positron emission tomography (1980) (5)
- Prognostic Significance of Fluorodeoxyglucose Uptake in Non–Small Cell Lung Cancer. A Blurry Picture? (2007) (5)
- Physiologic tomography: A new means for the non-invasive measurement of myocardial metabolism, blood flow and function (1980) (5)
- Molecular imaging of biological processes from microPET in mice to PET in patients (2002) (5)
- Error in parameter estimates with variations in flow: measurement of oxygen utilization with positron-emission tomography. (1985) (5)
- History of PET (2002) (5)
- COST EFFECTIVENESS OF FDG WHOLE BODY PET IN THE EVALUATION OF RENAL CELL CA (1995) (5)
- Effects of hypothyroidism on brain metabolism and its associations with neuropsychiatric impairments (2006) (5)
- Factor Analysis for automatic determination of myocardial flow in N-13-ammonia PET studies (2002) (5)
- Positron computed tomography and its applications in the young. (1985) (5)
- Diagnostic accuracy of FDG-PET in evaluation of dementia: International multicenter pooled brain scan and autopsy data (2000) (5)
- PET in children with seizures (1988) (5)
- Influence of ROI definition on the results of FDG-PET studies in patients with sarcomas (2007) (4)
- Same day rest-stress protocols for PET imaging with the new F-18 labeled BMS747158 myocardial perfusion tracer (2009) (4)
- O3-03-06 Plaque and tangle brain imaging using [F-18]FDDNP-PET differentiates Alzheimer's disease, mild cognitive impairment, and older controls (2004) (4)
- Dependence of /sup 13/NH/sub 3/ myocardial extraction and clearance on flow and metabolism. [Rabbits] (1982) (4)
- Simultaneous estimations of blood brain barrier (BBB) permeability and local cerebral blood volume (CBV) in human brain tumors with positron tomography and Ga-68 EDTA (1984) (4)
- Assess treatment response using FDOPA PET in patients with recurrent malignant gliomas treated with bevacizumab and irinotecan (2008) (4)
- CHAPTER 27 – Comparison of Ketamine/Midazolam versus Pentobarbital on [18F]Fluorodopa PET Kinetics in Monkeys (1998) (4)
- Nonlinearity in Modeling Receptor-Binding Ligands (1987) (4)
- Study design in the investigation of mood disorders with PET. (1985) (4)
- Elemental Fluorine to 8-Fluoropurines in One Step. (1997) (4)
- RELATIONSHIP OF LOCAL CEREBRAL GLUCOSE UTILIZATION AND RELATIVE PERFUSION IN STROKE AND EPILEPSY: DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 18F-FLUORODEOXY-GLUCOSE AND 13N-AMMONIA (1978) (4)
- Tracer Kinetic Modeling in Positron Computed Tomography (1983) (4)
- First-pass angiography in mice using FDG-PET: a simple method of deriving the cardiovascular transit time without the need of region-of-interest drawing (2005) (4)
- Regioselective Fluorination of Substituted Guanines with Dilute F2: A Facile Entry to 8-Fluoroguanine Derivatives. (1997) (4)
- Factors which affect cerebral uptake and retention of /sup 13/NH/sub 3/. [Testing in monkeys] (1977) (4)
- The feasibility of performing longitudinal measurements in mice using small animal PET imaging and a microfluidic blood sampling device (2007) (4)
- Physiologic tomography (PT): a new approach to in vivo measure of metabolism and physiological function. [Diagnostic effectiveness of positron transaxial tomography] (1976) (4)
- Application of integrated microfluidics to small animal positron emission tomography to obtain fully quantitative in vivo imaging (2006) (3)
- Metabolic tissue characterization in patients with acute myocardial infarction with positron tomography (1985) (3)
- Myocardial Blood Flow and Flow Reserve (2005) (3)
- Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance (2019) (3)
- Identification of residual viable tissue in chronic ECG Q wave infarcts with positron emission tomography (1985) (3)
- Predicting progression from MCI to dementia: Value of repeating PET scans in one year for subjects with initially indeterminate scans (2013) (3)
- In vivo [F-18]FDDNP microPET imaging of brain B-amyloid in a transgenic rat model of Alzheimer’s disease (2005) (3)
- Concepts and Techniques Used in Metabolic Tracer Studies (1986) (3)
- During Treatment Monitoring of Recurrent High-Grade Glioma (2010) (3)
- [F-18]FDDNP PET imaging of prion pathology in Gerstmann-Strausller-Scheinker disease (2007) (3)
- Positron emission tomography of the heart (1979) (3)
- COMPARISON OF F-18 LABELED BMS747158 PET AND TC-99M LABELED SPECT MYOCARDIAL PERFUSION IMAGING FOR DETECTION AND EVALUATION OF CORONARY ARTERY DISEASE (2010) (3)
- IN VIVO MEASURE OF REGIONAL CEREBRAL BLOOD FLOW AND BLOOD VOLUME BY MEANS OF STIMULATED X-RAY FLUORESCENCE. PART A. METHODOLOGY. (1971) (3)
- Validation Of The Noninvasive Tomographic Measure Of Regional Cerebral Glucose Metabolism In Man With 18f-2-fluoro-2-deoxy-glucose (1978) (3)
- [Whole body positron emission tomography in breast cancer]. (1993) (3)
- CEREBRAL GLUCOSE METABOLISM AS A FUNCTION OF AGE: THE INFLUENCE OF THE RATE CONSTANTS IN THE FDG METHOD (1982) (3)
- Nuclear medicine in the new millennium. (2000) (3)
- Metabolic and functional fate of viable myocardium by pet early after acute infarction (1991) (3)
- Single-Slice Contrasted with Multiple-slice Positron Tomographs—Reply (1979) (2)
- New Design Concepts for Quantitive Positron Emission Computed Tomography of the Brain (1983) (2)
- Quantitative assessments of glycolysis from single cells. (2015) (2)
- Applications of pet in the brain (1987) (2)
- Monitoring neoadjuvant chemotherapy of bone and soft tissue sarcomas with FDG-PET/CT (2006) (2)
- A quick method for calculation of the vascular mean transit time. (1974) (2)
- Optimal design of a new kinetic strategy for extracting FDG transport and uptake information in microfluidic multi-chamber cell culture chip coupled with PSAPD camera (2009) (2)
- Relationship of local cerebral glucose utilization and perfusion in brain ischemia: Determination by emission computed tomography of (F-18) fluorodeoxyglucose and (N-13) ammonia (1978) (2)
- Automatic Control System of a Microfluidic Blood Sampler for Quantitative microPET Studies in Small Laboratory Animals (2006) (2)
- OPTIMIZATION OF RADIOSYNTHESIS OF MOLECULAR TRACERS IN EWOD MICROFLUIDIC CHIP (2010) (2)
- Neuroimaging, neuropsychological, and genetic assessments for early detection of Alzheimer disease (1996) (2)
- Human cerebral metabolism studied during limitation in sensory inputs. (1981) (2)
- Clinical significance of reduced glucose uptake in myocardial regions with preserved blood flow in patients with coronary artery disease (1996) (2)
- Abstract 5746: ARC-P HS+: A versatile radiosynthesizer for the production of PET tracers (2012) (2)
- Noninvasive Detection of 47% Diameter Coronary Stenosis by Myocardial Emission Computed Tomography of Nitrogen-13 Ammonia During Pharmacologic Coronary Vasodilation in Intact Dogs (1980) (2)
- Preoperative determination of reversibility of wall motion abnormalities using F-18 fluorodeoxyglucose and N-13 ammonia positron tomography (1984) (2)
- POSITRON EMISSION TOMOGRAPHY (PET), COMPUTED TOMOGRAPHY (CT), AND MONOCLONAL ANTIBODY SCAN (MAb) FOR EVALUATION OF LYMPH NODE METASTASES IN PATIENTS WITH PROSTATE SPECIFIC ANTIGEN (PSA) RELAPSE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER. (1998) (2)
- Corrigendum to “Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death” [Biochem. Biophys. Res. Commun. 348 (2006) 1101–1106] (2006) (2)
- Prognostic value of 18F-FDOPA PET in treated low-grade gliomas with non-enhancing T2 changes on MRI (2013) (2)
- Influence of iterative reconstruction on parameter estimation with three-compartment kinetic modeling (1997) (2)
- Influence of APOE genotype and pet brain imaging on preclinical prediction of Alzheimer disease (2000) (2)
- chapter 10 – Pulse-Height Spectrometry (2012) (2)
- Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability. (1994) (2)
- Imaging , Diagnosis , Prognosis Treatment Response Evaluation Using 18 F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy (2014) (2)
- Correction for Adonai et al., Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography (2006) (1)
- A Message from the Academy of Molecular Imaging (2002) (1)
- A data portal for molecular imaging (2008) (1)
- F-18 labeled 3-fluorodiazepam (1985) (1)
- Positron Computed Tomography: A New Method for Quantitative Measurement of Cardiac Metabolism, Perfusion and Function of the Heart - I. Technical and Experimental Details (1983) (1)
- Outer-Quadrant Tumors : Comparison with Long-Term Clinical Outcome F-FDG PET for Staging Breast Cancer in Patients with Inner-Quadrant Versus (2005) (1)
- Assessing brain biochemistry in the early evaluation of dementia: can we afford the improved diagnostic accuracy obtained by incorporating cerebral metabolic data acquired with positron emission tomography into the clinical work-up? (2002) (1)
- Prognostic value of PET scans for predicting rate of functional decline of normal and MCI subjects over 3 years (2012) (1)
- Prognostic value of a normal rest-stress myocardial perfusion positron emission tomography (PET): a long term follow up study (1998) (1)
- Effects of finite spatial resolution on quantitative CBF images from dynamic PET (1985) (1)
- Validation of the non-invasive tomographic measure of regional cerebral glucose metabolism in man with [F-18]2-fluoro-2-deoxyglucose (1978) (1)
- PRINCIPLES OF BIOCHEMICAL ASSAYS WITH POSITRON CT (1984) (1)
- N-Fluorolactams: Rapid, Mild, and Regiospecific Fluorinating Agents. (1990) (1)
- Reply No. 1 (1976) (1)
- The prevalence of viable myocardium in 288 patients with congestive heart failure (1998) (1)
- Molecular and Cellular Pathobiology 18 F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers (2011) (1)
- Quantification of Absolute Myocardial Perfusion With Dynamic Positron Emission Tomography (2005) (1)
- Diagnostic value of 18F-FDG PET/CT and dedicated bone imaging in childhood sarcoma (2011) (1)
- DEVELOPMENT OF AN AUTOMATED REGISTRATION ALGORITHM FOR DETECTION AND CORRECTION OF PATIENT MOVEMENT IN CARDIAC PET IMAGING (1992) (1)
- TUMOR SIZE ESTIMATION BY PET FDG IMAGING (1992) (1)
- Practical procedures and pharmacological applications of quantitative PET. (1993) (1)
- Metabolic fate of L-(N-13) glutamate in normal isolated myocardium (1984) (1)
- Effects of adjuvant therapy on cerebral function during short-term and long-term memory tasks (2012) (1)
- Accuracy of early pet blood flow and metabolic measurements for predicting late improvement in the clinical infarct zone (1991) (1)
- PET with F-18 fluorodeoxyglucose measures of local brain activity and memory in schizophrenia and in depression (1984) (1)
- In vivo kinetics of (H-3)spiperone in rat brain (1984) (1)
- Alterations in local cerebral metabolic rates for glucose (LCMRGlc) in childhood epilepsies as determined with FDG and PET (1985) (1)
- Parietal and temporal cortical activity associated with cognitive symptoms and depression in chemotherapy treated breast cancer survivors 5 to 10 years after end of chemotherapy (2007) (1)
- IN VIVO MEASURE OF REGIONAL CEREBRAL BLOOD FLOW AND BLOOD VOLUME BY MEANS OF STIMULATED X-RAY FLUORESCENCE. PART B. INSTRUMENTATION. (1971) (1)
- Refractory Neonatal Seizures: Determination of Local Cerebral Metabolic Rates for Glucose (LCMRglc) with 2-Deoxy-2[18F] Fluoro-D-Glucose (FDG) and Positron Emission Tomography (PET) (1987) (1)
- [Positron-computer tomography: a new method for the quantitative determination of metabolism, blood supply and function of the heart]. (2008) (1)
- Usefulness of [18F]-deoxyglucose local metabolic rates in aphasia. (1979) (1)
- P2-374 MR-guided 3D PET mapping of longitudinal changes in regional cerebral metabolism of normal subjects (2006) (1)
- Multi-pot radiosynthesizer capable of high-pressure reactions for production of [18F]FAC and analogs (2011) (1)
- Signal Amplification Technique (SAT): an approach for improving resolution and reducing image noise in computed tomography (1981) (1)
- Diverse nucleophilic syntheses on the ELIXYS multi-pot, cassette-based radiosynthesizer (2012) (1)
- Value of FDG-PET in predicting rate of subsequent cognitive decline among cognitively normal and mildly impaired subjects (2012) (1)
- PET F-18 WHOLE BODY BONE SCANS: TECHNIQUE AND APPLICATIONS WITH A HIGH RESOLUTION SYSTEM (1989) (1)
- RELATION BETWEEN SEVERITY OF RELATIVE MYOCARDIAL BLOOD FLOW REDUCTION AND GLUCOSE METABOLIC ACTIVITY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE.: P2 (1986) (1)
- Cerebral protein synthesis rates in vivo: Estimation via biochemical analyses and tracer kinetic modeling (1985) (1)
- Kinetic characterization of /sup 13/NH/sub 3/ and (/sup 13/N)glutamine metabolism in rabbit heart (1984) (1)
- F-18 labeled BMS747158 PET myocardial perfusion imaging identifies more severe and extensive stress induced myocardial ischemia than Tc-99m Sestamibi SPECT (2010) (1)
- 6-[18F]Fluoro-L-DOPA kinetics with PET: Correlation with its biochemical metabolism in normal and MPTP-treated monkeys (1991) (1)
- The Role of Positron Emission Tomography in the Diagnosis of Alzheimer's Disease (2004) (1)
- Effects of inhibition of. beta. -oxidation on tissue kinetics of C-11 palmitate in normal myocardium (1985) (1)
- Human brain development in infants with PET and FDG (1985) (1)
- Title Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography (2013) (0)
- Combining PET and CT: effect on volume measurements (2002) (0)
- A simplified method for measuring glucose utilization in mice using small animal positron emission tomography and fluorine-18 deoxyglucose (2006) (0)
- Brain metabolism and memory in age differentiated healthy adults (1984) (0)
- Introduction to the Blood–Brain Barrier: Measurement of blood–brain permeability in humans with positron emission tomography (1998) (0)
- Measurements of cerebral blood flow and glucose metabolism in human brain tumors with positron emission tomography (1985) (0)
- Impairment of voluntary movement in cerebral palsy and cerebellar metabolism (2008) (0)
- DIAGNOSTIC METHODS (1972) (0)
- Metabolism of 6-[18F]-fluoro-L-dopa in Primates (1987) (0)
- Streamlined quantification of absolute MBF at rest and stress with flurpiridaz F-18 injection PET in normal subjects and patients with coronary artery disease (CAD) (2011) (0)
- Regional Myocardial Metabolism by Positron Emission Tomography (1988) (0)
- Factor analysis for automatic generation of in and output functions in oncological PET studies (2001) (0)
- PET provides analytical measurements of drug interactions with, and EFFECT on, chemical systems of the human body (1992) (0)
- Tumor FDG-uptake after the initial cycle of chemotherapy and histopathologic response to neoadjuvant therapy in high-grade soft tissue sarcomas (2008) (0)
- Regional brain metabolism and circulating inflammatory cytokines in breast cancer patients after adjuvant chemotherapy (2011) (0)
- Comparison of cerebral regional glucose metabolic relationships in resting and auditory stimulated states (1984) (0)
- Altered amino acid uptake associated with chemotherapy and radiation exposure in subjects with primary brain tumors (2011) (0)
- Radiation necrosis versus recurrent tumor: Value of 18F-FDOPA PET in patients with high-grade gliomas (2009) (0)
- P-203 Cognitive and cerebral metabolic effects of celecoxib in people with age-related memory complaints (2007) (0)
- 23-4 Gender differences in effect of mental stress on myocardial blood flow: A quantitative PET study (1997) (0)
- Reproducibility study of a non-invasive positron CT (PCT) technique using O-15 water for screening relative cerebral blood flow responses due to neurobehavior interventions (1984) (0)
- Positron computed tomography: current state, clinical results and future trends (1980) (0)
- Synthesis of an 18F labeled pyrazole-based Hsp90 inhibitor for PET imaging of cancers (2008) (0)
- Current BER Scientists: Principal Investigators (2001) (0)
- 18F-FLT-PET uptake dynamics and overall survival predictions for patients with recurrent high-grade glioma on bevacizumab therapy (2011) (0)
- Improvement in heart failure symtoms after revascularization in patients with ischemic cardiomyopathy predicted by PET (1995) (0)
- Positron Emission Tomography Detects Metabolic Viabilit in Myocardium With Persistent 24‐Hour Single‐Photon Emission Computed Tomography 201T1 Defects (1992) (0)
- 18f-FDG-PET imaging as an early survival predictor in patients with high-grade soft tissue sarcomas undergoing neoadjuvant therapy. (2012) (0)
- Radiolabeled acetate kinetics and tricarboxylic acid cycle flux in the rat heart (1987) (0)
- 5-(2-[18 F]Fluoroethyl)-4-Methylthiazole Probe For Positron Emission Tomography Of The Central Nervous System (2014) (0)
- HOW DOES THE NUMBER OF NORMALS AFFECT THE RELIABILITY OF A NORMAL REFERENCE DATABASE (1992) (0)
- 214 Noninvasive Monitoring of Immunotherapeutic Responses in Glioblastoma Using Novel Imaging Techniques (2018) (0)
- ANOMALOUS $sup 5$/$sub 2$$sup +$ AND $sup 7$/$sub 2$$sup +$ STATES IN $sup 99$Rh FROM THE DECAY OF 21 MIN $sup 99$Pd. (1969) (0)
- F-18 FDOPA kinetics to diagnose Parkinson's disease: Simplifications for use in clinical practice (2009) (0)
- A study of the FDG model in the presence of an altered blood brain barrier (BBB) and glucose metabolic/flow relationships in human brain tumors with PET (1985) (0)
- Effects of anoxia, pyruvate, and lactate on distribution of N-13 glutamate in myocardium (1984) (0)
- Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington??s disease (1987) (0)
- Local cerebral glucose utilization measured with 18F-2-fluoro-2-deoxyglucose (1978) (0)
- F ] FLUOROETHYL )-4-METHYLTHIAZOLE PROBE FOR POSITRON EMISSION TOMOGRAPHY OF THE CENTRAL NERVOUS SYSTEM (2014) (0)
- in Patients with Inner-Quadrant Versus Outer-Quadrant Tumors: Comparison with Long-Term Clinical Outcome (2014) (0)
- Is there a correlation between tumor proliferative and glycolytic phenotype in high grade soft tissue sarcoma (2010) (0)
- Interobserver variability of assessment of tumor response by FDG-PET (2007) (0)
- Metabolic tumor volume by 18F-FDOPA PET is predictive of treatment response in patients with recurrent high-grade gliomas on anti-angiogenic therapy as early as 2 weeks after therapy initiation (2012) (0)
- THE STUDY OF CHANGES IN LOCAL CEREBRAL GLUCOSE METABOLISM ASSOCIATED WITH ALTERED MOOD STATES IN PATIENTS WITH AFFECTIVE DISORDERS (1984) (0)
- Response to Larry R. White's Letter to the Editor Titled “Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin's Lymphoma: Statistical Errors in Fueger et al. (2009)” (2012) (0)
- Tumor glucose utilization predicts response to epidermal growth factor receptor kinase inhibitors (2006) (0)
- Application of the ''bootstrap'' technique to understanding cerebral interregional metabolic relationships (1984) (0)
- TEMPORAL SAMPLING EFFECTS ON PARAMETER ESTIMATION ACCURACY IN KINETIC POSITRON COMPUTED TOMOGRAPHIC (PCT) STUDIES (1984) (0)
- Determination of the mouse brain FDG rate constants for calculation of cerebral glucose metabolic rates in mice (2007) (0)
- [Positron computed tomography: a new method for quantitative determination of cardiac metabolism, blood circulation and function. I. Technical and experimental bases]. (1983) (0)
- Institute for Molecular Medicine Research Program (2012) (0)
- Prediction of response to epidermal growth factor receptor kinase inhibitor (erlotinib) in advanced NSCLC by PET/CT: A prospective study (2008) (0)
- NIMG-36. DELINEATION OF IMMUNE RESPONSES AFTER IMMUNOTHERAPY IN GLIOBLASTOMA USING PET AND MRI (2017) (0)
- Evaluationof MyocardiaiMetaboiism,withN-13-andC-i 1-LabeledAmino Acids and PositronComputedTomography (2006) (0)
- Diagnosis — Methods for Evaluating Myocardial Microcirculation in Patients (1982) (0)
- Measurement of regional cerebral metabolic rate for glucose in the human subject with (F-18)-2-deoxy-2-fluoro-d-glucose and emission computed tomography: validation of the method (1977) (0)
- Post-treatment tumor FLT uptake does not correlate with tumor proliferation by Ki-67 staining in patients with soft tissue sarcoma (2010) (0)
- Glucose metabolic phenotyping and prediction of tumor grade in soft tissue and bone tumors by 18F-FDG PET imaging (2009) (0)
- Microfluidic technology platforms for synthesizing, labeling and measuring the kinetics of transport and biochemical reactions for developing molecular imaging probes (2009) (0)
- Letter: Production of short-lived isotopes by charged particle accelerators. (1973) (0)
- Comprar Physics in Nuclear Medicine, 4th Edition | Michael E. Phelps | 9781416051985 | Saunders (2012) (0)
- C-11 acetate traces both oxidative metabolism and blood flow in human myocardium (1990) (0)
- PET: biological imaging of the brain (1993) (0)
- 811-3 Beneficial Effect of β-Blockade on Myocardial Blood Flow and Vasodilator Capacity in Humans (1995) (0)
- Striatal 18F-DOPA metabolism with PET-CT in patients with and without Parkinson's disease (2011) (0)
- Multimodality imaging of cytostatic response to therapy in tumor-bearing mice (2007) (0)
- Optimizing the quantitative analysis of cerebral glucose utilization rates in mouse using FDG-PET imaging and a 3D image deformation method (2007) (0)
- Effect of model configuration on CMRO/sub 2/ measurements by dynamic PET and O-15 oxygen (1985) (0)
- Efficient Conversion of 1-Aryl-3,3-dialkyltriazenes to Phenols and Oxygen-18 Labeled Phenols. (1991) (0)
- Evaluation ofPET Charactenstics (1987) (0)
- 18F-FLT PET and 18F-FDOPA PET in evaluate treatment response: Identify the best prognostic marker (2013) (0)
- MYOCARDIAL ISCHEMIA Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis (2005) (0)
- Radiation treatment to the neck is significantly associated with diffusely increased thyroid FDG-uptake (2006) (0)
- Positron Emission Tomography Detects Metabolic Viabilit in Myocardium With Persistent 24-Hour Single-Photon Emission Computed Tomography 201 T 1 Defects (2005) (0)
- The 5-parameter FDG model: Sampling requirements and validation studies (1985) (0)
- Optimizing the quantitative in vivo imaging for longitudinal studies in rat brain using FDG and microPET (2006) (0)
- Minicyclotron-based technology for the production of positron-emitting labelled radiopharmaceuticals (1983) (0)
- Evaluation of metabolic imaging for assessment of tumor response to mTOR inhibitors (2007) (0)
- INCREASED FDG UPTAKE IN REPERFUSED CANINE MYOCARDIUM REPRESENTS SUSTAINED ANAEROBIC METABOLISM: P22 (1986) (0)
- Contents, Vol. 6, 1971 / Foreword (1971) (0)
- EVALUATION OF FLUORODEOXYGLUCOSE(FDG) AS A GLUCOSE ANALOG IN MYOCARDIUM WITH 2‐t‐GLUCOSE.: F5 (1983) (0)
- MONITORING CHANGES IN GLUCOSE METABOLISM IN LIVER MELANOMA METASTASES SEQUENTIALLY TREATED WITH GM-CSF AND CYCLOPHOSPHAMIDE WITH FDG PARAMETRIC IMAGING AND PET (1992) (0)
- REAL-TIME MONITORING GLUCOSE UTILIZATION IN SINGLE CELL USING A CELL CULTURE CHIP WITH AN EMBEDDED DETECTOR (2008) (0)
- Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas (2011) (0)
- Optimizing the total scanning time needed for quantitative mouse brain FDG-PET studies (2007) (0)
- Halogen Exchange Reactions Between Alkyl Halides and Aqueous Hydrogen Halides. A New Method for Preparation of Alkyl Iodides from Alkyl Halides. (1992) (0)
- Correlation of FDOPA-PET uptake with proliferative activity and malignancy grade in brain tumors (2009) (0)
- Reply (1988) (0)
- MYC-Overexpressing Human Basal-Like Breast Cancers F-Fluorodeoxy-glucose Positron Emission Tomography Marks 18 (2011) (0)
- Supplemental Data A Phenotypic Small-Molecule Screen Identifies an Orphan Ligand-Receptor Pair that Regulates Neural Stem Cell Differentiation (2007) (0)
- In vivo imaging of beta-amyloid load in transgenic rodents with [F-18]FDDNP microPET (2005) (0)
- Metabolism in Rabbit Myocardium (2005) (0)
- P2-300 In vivo quantification of neuronal loss and neuropathological deposition in Alzheimer’s disease with PET (2006) (0)
- Noninvasive measurement of local myocardial glucose uptake with F-18 deoxyglucose and positron tomography (1982) (0)
- Cell surface expression of an engineered antibody as a PET reporter gene for in vivo PET imaging (2008) (0)
- QUANTITATIVE DYNAMIC HIDA STUDIES FOR EVALUATION OF PEDIATRIC LIVER TRANSPLANT FUNCTION: METHODS AND RESULTS.: D2 (1988) (0)
- Fitting 4-compartment kinetics with a 3-compartment model (1984) (0)
- NI-6818F-FDOPA PET IN TREATED LOW-GRADE GLIOMAS WITH NON-ENHANCING T2 CHANGES ON MRI IS PROGNOSTIC OF TUMOR PROGRESSION AND OVERALL SURVIVAL. (2014) (0)
- Role of cyclotrons and positron imaging in the future of nuclear medicine. (1978) (0)
- DYNAMIC,GATEDAND HIGH RESOLUTIONIMAGINGWITH THE ECAT III (1986) (0)
- LABORATORY OF NUCLEAR MEDICINE AND RADIATION BIOLOGV 900 VETERAN AVENUE UNIVERSITY OF CALIFORNIA, LOS ANGELES, CALIFORNIA 90024 AND DEPARTMENT OF RADIOLOGICAL SCIENCES UCLA SCHOOL OF MEDICINE, LOS AMGELES, CALIFORNIA 90024 These studies were supported by Contract #DE-AM03-76-SF00012 between the U.S. (2009) (0)
- FDG PET Studies in Slowly Progressive Motor Neuron Disease (1987) (0)
- A novel continuous nanovolumetric blood sampler for quantitative analysis in small animal studies (2008) (0)
- Microfluidics to optimize antibody fragment engineering (2009) (0)
- Prescription of Alzheimer's-specific drugs and long-term preservation of language function are positively associated with early release of regional cerebral metabolic data in a multi-center prospective randomized trial (2012) (0)
- WHOLE-BODY PET WITH FDG FOR DETECTION OF BOTH PRIMARY AND METASTATIC MALIGNANCIES: AN UPDATE OF THE CLINICAL EXPERIENCE (1992) (0)
- Regional myocardial perfusion evaluated in humans at rest using rubidium-82 with gamma-camera imaging (1987) (0)
- PNAS Plus Significance Statements (2014) (0)
- CONTINUING EDUCATION PET Imaging: An Overview and Instrumentation (2014) (0)
- Routine radiopharmaceutical production for positron emission tomography in a clinical setting (1985) (0)
- Toward on-demand production of diverse PET tracers: Repeatable, multi-step synthesis of [18F]FDG on a compact, electronically-actuated droplet-based microfluidic platform (2011) (0)
- Quantification of glucose metabolic activity of human tumor xenografts in mice (2007) (0)
- A correlative study of clinical-pathologic characteristics of human brain tumors and blood brain barrier (BBB) permeability evaluated with Ga-68 EDTA and positron emission tomography (1985) (0)
- Accuracy of imaging-based determinations of [F-18]-5-Fluorouracil uptake in rats used for radiodosimetry calculations (2006) (0)
- Objective neuropsychologic performance is associated with levels of medial frontal, temporal, cerebellar activity in brains of breast cancer patients soon after adjuvant chemotherapy (2011) (0)
- CHAPTER 26 – Validation of an [18F]FIuorodeoxyglucose–PET Protocol in Conscious Vervet Monkey (1998) (0)
- Monitoring deoxyglucose treatment with FDG and FLT PET (2007) (0)
- Feasibility of using radiofluorinated perisynaptic calcium channel ligands to image early neurodegeneration (2007) (0)
- "Molecular Imaging" (2006) (0)
- IC-P2-093: Differential FDDNP-PET patterns identify subgroups of middle-aged and older adults (2008) (0)
- Flux of Nitrogen-13 from L-(N-13)Glutamate in isolated myocardium (1985) (0)
- All Analysis of Signal Amplification Using Small Detectors in Positron Emission Tomography (1982) (0)
- Prognostic value of 18F-FDOPA PET in patients with treated low-grade gliomas (2010) (0)
- A STUDY OF HUMAN MYOCARDIAL THALLIUM KINETICS.: P4 (1988) (0)
- Value of FDG-PET in predicting dementia within 3 years among patients clinically diagnosed with mild cognitive impairment (2011) (0)
- Emission Tomography (2005) (0)
- PET IMAGING IN PATIENTS WITH BIOCHEMICAL FAILURE FOLLOWING TREATMENT FOR LOCALIZED PROSTATE CANCER (1998) (0)
- A STUDY OF PRE‐ AND POSTSYNAPTIC ACTIONS OF THE DOPAMINERGIC SYSTEM WITH PET.: B1 (1986) (0)
- Role of Positron Emission Tomography in Pediatric Epilepsy Surgery (1989) (0)
- Quantitative assessment of absolute cbf values measured by positron computed tomography(PCT) and O-15 water (1984) (0)
- EVALUATION OF BLOOD BRAIN BARRIER PERMEABILITY IN HUMAN BRAIN TUMORS WITH POSITRON TOMOGRAPHY AND Ga‐68 EDTA.: H8 (1983) (0)
- PETbox: A benchtop high throughput preclinical PET system (2009) (0)
- ValIdation of Tomographlc Measurement of Cerebral Blood Volume with C-il-Labeled Carboxyhemoglobin (2006) (0)
- Assessment of early response to tyrosine kinase inhibitor (erlotinib) in stage IIIB/IV NSCLC by PET/CT (2011) (0)
- 808. Monitoring of Transgene Expression in Cancer Patients with Positron Emission Tomography (PET) (2005) (0)
- Remembering Sanjiv (Sam) Gambhir, MD, PhD (2020) (0)
- PARALLEL SCREENING OF IN SITU CLICK CHEMICAL LIBRARIES IN INTEGRATED MICROFLUIDIC DEVICES (2008) (0)
- N-13 ammonia for the noninvasive evaluation of myocardial blood flow by positron emission computed tomography (1979) (0)
- Evidence for the absence of cerebral glucose-6-phosphatase activity in glycogen storage disease type I (Von Gierke's disease) (1981) (0)
- New kinetic strategy for extracting FDG transport and uptake information in microfluidic multi-chamber cell culture chip coupled with PSAPD (2009) (0)
- System for total body pet of skeletal and soft tissues (1991) (0)
- FDG-PET is more accurate than CT at assessing early treatment response to neoadjuvant therapy in soft tissue sarcomas (2008) (0)
- Radiodosimetry estimates for [F-18]5-Fluorouracil derived from imaging-based and harvesting-based methods in rats (2007) (0)
- Evaluation of Myocardiai Metaboiism, withN-13-andC-i 1-Labeled Amino AcidsandPositronComputedTomography (1982) (0)
- ARE GENDER OR PHARMACOLOGIC STRESS-SPECIFIC REFERENCE NORMAL DATABASES NECESSARY FOR QUANTITATIVE ANALYSIS OF STRESS N-13 AMMONIA PET IMAGES? (1992) (0)
- REGISTRATION OF FDG-PET TEST-RETEST STUDIES IN PRIMATES (1994) (0)
- Nitrogen-13-labeled L-amino acids for in vivo assessment of local myocardial metabolism (1981) (0)
- Changes in regional brain metabolism associated with insulin resistance in postmenopausal women (2006) (0)
- Tumor metabolic phenotyping and treatment stratification by positron emission tomography (2011) (0)
- Overview: Transforming in Vivo Diagnostics into a Molecular Measurement Science. (2006) (0)
- Validity of using liver time activity curve as the input function for FDG kinetic analysis in mouse PET studies (2007) (0)
- How accurately can FDG-PET scans predict individual rates of cognitive decline? (2006) (0)
- Noninvasive measurement of regional myocardial glucose metabolism by positron emission computed tomography. [Dogs] (1980) (0)
- STRATEGIES FOR THE STUDY OF BEHAVIORAL DISORDERS WITH POSTRON CT: USE OF STIMULATION PARADIGMS IN PATIENTS WITH NEUROPATHOLOGY (1984) (0)
- Human biodistribution and dosimetry of the nucleoside analogue [18F]FAC in humans (2008) (0)
- Kinetics of 18F-FAC and L-18F-FMAC PET probes for imaging nucleoside salvage metabolism (2010) (0)
- Electrophilic and Nucleophilic Approaches to the Synthesis of 3-Fluorodiazepam. (1987) (0)
- EVALUATION OF BRAIN TUMORS WITH T1‐201 SPECT STUDIES: CORRELATION WITH HISTOLOGICAL RESULTS.: A2 (1988) (0)
- Using siRNA as a tool to dissect the molecular pathway for FDG uptake in tumor cells (2007) (0)
- KINETIC STUDIES OF HUMAN BRAIN TUMORS WITH POSITRON COMPUTED TOMOGRAPHY (PCT) (1984) (0)
- Local cerebral glucose metabolism (LCMRGlc) in mood disorders (1985) (0)
- Prescription pattern of Alzheimer-specific drugs is positively associated with immediate release of brain PET scan data in the Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) trial (2012) (0)
- Functional Data Analysis 1. Human Growth Data: Looking at Velocity and Acceleration (1997) (0)
- A new method for quantitating total lesion glucose metabolic changes in serial tumor FDG PET studies (1994) (0)
- Evaluation of cancer detection with whole-body positron emission tomography (PET) and 2-[F-18]fluoro-2-deoxy-D-glucose (1993) (0)
- AN ANIMAL MODEL FOR HUMAN BREAST CARCINOMA: POTENTIAL FOR IN VIVO IMAGING WITH A DEDICATED ANIMAL PET SYSTEM (1991) (0)
- The high diagnostic value of F-18 FDOPA PET and PET-CT in pheochromocytoma (2008) (0)
- An automated system for quantification/analysis of mouse PET images (2009) (0)
- Real time blood plasma separation in a microfluidic chip (2009) (0)
- The NHLBI Centers Program: The Sun Also Rises (2005) (0)
- Small-Animal PET: A Technology That Changed Our Field (2020) (0)
- A Conversation Between Michael Phelps and Jason Lewis (2019) (0)
- Positron Emission Tomographic Scans in Depressive Disorders-Reply (1988) (0)
- Changes in regional brain metabolism following initial therapy for breast cancer (2011) (0)
- Impact of18F-FDG PET on Managing Patients with Colorectal Cancer: The Referring Physician’s Perspective (2001) (0)
- Longitudinal changes in regional brain metabolism associated with endocrine therapy in prospectively studied breast cancer (BC) patients (2012) (0)
- Contents, Vol. 20, Supplement 1, 1987 (1987) (0)
- Somatotopic Mapping of the Primary Motor Cortex Activation Studies With Cerebral Blood Flow and Positron Emission Tomography in Humans : (2002) (0)
- Emission computed tomography: a new technique for the quantitative physiologic study of brain and heart in vivo (1978) (0)
- Quantification of dynamic PET studies in prostate cancer: Which model applies for C-11-acetate? (2002) (0)
- Investlg atlon of [ ‘8 F] 2- Fluoro-2--Deoxyglu cose for the Measure of Myocardlal Glucose Metabolism (2006) (0)
- A novel tracer injection system for PET imaging of small animals (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael E. Phelps?
Michael E. Phelps is affiliated with the following schools:
